Dr. Ashley Battarbee, MD
Claim this profileUniversity of Alabama
Studies Type 2 Diabetes
Studies Pregnancy
3 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Ashley Battarbee, MD is currently running
Insulin Management Strategies
for Diabetes during Pregnancy
There is a fundamental gap in understanding the maternal and neonatal effects of antenatal corticosteroid (ACS) administration in women with threatened preterm birth (PTB) who have diabetes. Since the initial discovery of ACS for neonatal benefit in 1972, more than 40 randomized controlled trials have been performed evaluating its efficacy. However, none of these trials have included women with T2DM, and there is limited data among women with gestational diabetes. While ACS have been shown to reduce neonatal morbidity associated with PTB in non-diabetic women, the side effects of ACS (maternal hyperglycemia and fetal hyperinsulinemia) may mitigate the neonatal benefit of ACS in women with diabetes. Before neonatal benefit of ACS can be evaluated in this population, the first step is to optimize maternal glycemic control after ACS. Previous studies evaluating maternal hyperglycemia after ACS have been limited by small sample size, retrospective study design, or insufficient glucose data. Use of continuous glucose monitoring (CGM) in a randomized clinical trial provides a unique opportunity to overcome these challenges. Our long-term goal is to improve maternal and child health among women with diabetes as an independently funded clinical researcher. The research objectives of this proposal are to test the efficacy of three treatment strategies at achieving maternal glycemic control after ACS and evaluate the association between maternal glycemic control and neonatal outcomes. Our central hypothesis is that treatment with a continuous insulin infusion will improve maternal glycemic control, which is key to improving neonatal outcomes, but at the cost of less patient satisfaction and more health resource utilization. This hypothesis will be tested by pursuing the following specific aims: 1) Test the efficacy of three treatment strategies (addition of sliding scale insulin, up-titration of home insulin, and continuous insulin infusion) at achieving maternal glycemic control after ACS and 2) Quantify the association between maternal glycemic control after ACS and neonatal morbidity. Completion of these aims will determine the optimal strategy to achieve maternal glycemic control after ACS and inform a larger, multicenter trial to improve neonatal outcomes among women with diabetes and threatened PTB.
Recruiting1 award Phase 24 criteria
Educational Game vs Genetic Counseling
for Prenatal Screening Education
Advancements in prenatal genetic screening have significantly improved the identification of chromosomal abnormalities and heritable conditions during pregnancy, yet current standards for patient education in this domain are largely ineffective. The most effective approach to education about prenatal screening is one-on-one genetic counseling, but due to the limited number of counselors this is not feasible, especially in rural and frontier areas. The investigators will address this national problem using a novel education game that can more effectively address this gap in healthcare decision-making.
Recruiting1 award N/A
More about Ashley Battarbee, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ashley Battarbee, MD has experience with
- CGM
- Antenatal Corticosteroids
- Continuous Insulin Infusion
- Sliding Scale Insulin
- Up-Titration Of Home Insulin
- Genetic Counseling
Breakdown of trials Ashley Battarbee, MD has run
Type 2 Diabetes
Pregnancy
Gestational Diabetes
Diabetes Mellitus
Pregnancy Complicated by Malaria
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ashley Battarbee, MD specialize in?
Ashley Battarbee, MD focuses on Type 2 Diabetes and Pregnancy. In particular, much of their work with Type 2 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Ashley Battarbee, MD currently recruiting for clinical trials?
Yes, Ashley Battarbee, MD is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Ashley Battarbee, MD has studied deeply?
Yes, Ashley Battarbee, MD has studied treatments such as CGM, Antenatal Corticosteroids, Continuous Insulin Infusion.
What is the best way to schedule an appointment with Ashley Battarbee, MD?
Apply for one of the trials that Ashley Battarbee, MD is conducting.
What is the office address of Ashley Battarbee, MD?
The office of Ashley Battarbee, MD is located at: University of Alabama, Birmingham, Alabama 35233 United States. This is the address for their practice at the University of Alabama.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.